ABBV vs PCH · P/E 81, rev $61.16B vs P/E 51, rev $1.06B
AbbVie Inc (ABBV) versus PotlatchDeltic Corp (PCH) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
PotlatchDeltic Corp (PCH) is a reit - specialty company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported PCH revenue for 2024-12-31 was $1.06B. Net income was $21.9M. Revenue was up 3.7% from 2023-12-31 to 2024-12-31. PCH currently screens at market cap $3.23B and trailing P/E 50.9.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. PCH currently screens at market cap $3.23B and trailing P/E 50.9.
Not investment advice. Open the ABBV and PCH stock pages for the full models.
Not investment advice.